Q0F — IHH Healthcare Bhd Share Price
Last trade - 00:00- SG$18.11bn
- SG$23.22bn
- MYR24.38bn
- 75
- 29
- 77
- 67
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 28.65 | ||
| PEG Ratio (f) | 185.88 | ||
| EPS Growth (f) | 0.15% | ||
| Dividend Yield (f) | 1.46% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.98 | ||
| Price to Tang. Book | 5.78 | ||
| Price to Free Cashflow | 51.68 | ||
| Price to Sales | 2.42 | ||
| EV to EBITDA | 12.42 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.25% | ||
| Return on Equity | 8.01% | ||
| Operating Margin | 17.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | MYRm | 13,404.6 | 17,131.76 | 17,988.69 | 20,934.84 | 24,383 | 25,938.78 | 28,212.98 | 10.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -55.54 | +533.34 | -9.97 | -0.12 | +45.43 | -11.69 | +13.06 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company operates a network of over 80 hospitals across approximately 10 countries. The Company’s business segments include Hospital and Healthcare, Labs, PLife REIT, and Others. The Company’s Hospital and Healthcare segment operates in Singapore, Malaysia, India, Greater China, Turkey, Europe, and Southeast Asia. The Labs segment provides clinical, pathology, and genetics diagnostic laboratory services. The PLife REIT segment functions as a real estate investment trust. The Company’s subsidiaries include Integrated Healthcare Holdings Limited, Integrated Healthcare Turkey Yatirimlari Limited, IHH Financial Services Pte. Ltd., and IHH Laboratories Holdings Sdn. Bhd.
Directors
- Mohammed Azlan bin Hashim NEC (64)
- Chi-Keon Loh CEO (47)
- Joerg Ayrle CFO (52)
- Abdul Aziz Baba CEX (65)
- Tahsin Guney CEX (54)
- Heng Joo Joe Sim COO (49)
- Angela Ryan CHO (48)
- Ida Suryati Binti Ab Rahim GCN (48)
- Nili Shayrina binti Saat OTH (46)
- Stephen Byrne OTH
- Mehmet Ali Aydinlar NED (64)
- Farid bin Mohamed Sani NED (45)
- Tunku Alizakri Bin Raja Muhammad Alias NED (51)
- Takeshi Saito NED (49)
- Masato Sugahara NED (58)
- Muthanna Bin Abdullah NID (61)
- Ai Lin Ong NID (65)
- Satoshi Tanaka NID (63)
- Jill Watts NID (62)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- May 21st, 2010
- Public Since
- April 2nd, 2012
- No. of Shareholders
- 7,523
- No. of Employees
- 70,000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 8,836,153,463
- Address
- Level 11 Block A, KUALA LUMPUR, 59100
- Web
- https://www.ihhhealthcare.com/
- Phone
- +60 322989898
- Auditors
- KPMG
Latest News for Q0F
Upcoming Events for Q0F
Q2 2025 IHH Healthcare Bhd Earnings Release
Q3 2025 IHH Healthcare Bhd Earnings Release
Similar to Q0F
Alliance Healthcare
Singapore Exchange Securities Trading Ltd
Aoxin Q & M Dental
Singapore Exchange Securities Trading Ltd
Asiamedic
Singapore Exchange Securities Trading Ltd
Asia Vets Holdings
Singapore Exchange Securities Trading Ltd
Beverly JCG
Singapore Exchange Securities Trading Ltd
FAQ
As of Today at 03:13 UTC, shares in IHH Healthcare Bhd are trading at SG$2.05. This share price information is delayed by 15 minutes.
Shares in IHH Healthcare Bhd last closed at SG$2.05 and the price had moved by +13.26% over the past 365 days. In terms of relative price strength the IHH Healthcare Bhd share price has outperformed the FTSE Developed Asia Pacific Index by +4.6% over the past year.
The overall consensus recommendation for IHH Healthcare Bhd is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe IHH Healthcare Bhd dividend yield is 1.47% based on the trailing twelve month period.
Last year, IHH Healthcare Bhd paid a total dividend of MYR0.10, and it currently has a trailing dividend yield of 1.47%. We do not have any data on when IHH Healthcare Bhd is to next pay dividends.
We do not have data on when IHH Healthcare Bhd is to next pay dividends. The historic dividend yield on IHH Healthcare Bhd shares is currently 1.47%.
To buy shares in IHH Healthcare Bhd you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SG$2.05, shares in IHH Healthcare Bhd had a market capitalisation of SG$18.11bn.
Here are the trading details for IHH Healthcare Bhd:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: Q0F
Based on an overall assessment of its quality, value and momentum IHH Healthcare Bhd is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in IHH Healthcare Bhd is SG$2.49. That is 21.64% above the last closing price of SG$2.05.
Analysts covering IHH Healthcare Bhd currently have a consensus Earnings Per Share (EPS) forecast of MYR0.22 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like IHH Healthcare Bhd. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -20.48%.
As of the last closing price of SG$2.05, shares in IHH Healthcare Bhd were trading -3.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The IHH Healthcare Bhd PE ratio based on its reported earnings over the past 12 months is 28.65. The shares last closed at SG$2.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
IHH Healthcare Bhd's management team is headed by:
- Mohammed Azlan bin Hashim - NEC
- Chi-Keon Loh - CEO
- Joerg Ayrle - CFO
- Abdul Aziz Baba - CEX
- Tahsin Guney - CEX
- Heng Joo Joe Sim - COO
- Angela Ryan - CHO
- Ida Suryati Binti Ab Rahim - GCN
- Nili Shayrina binti Saat - OTH
- Stephen Byrne - OTH
- Mehmet Ali Aydinlar - NED
- Farid bin Mohamed Sani - NED
- Tunku Alizakri Bin Raja Muhammad Alias - NED
- Takeshi Saito - NED
- Masato Sugahara - NED
- Muthanna Bin Abdullah - NID
- Ai Lin Ong - NID
- Satoshi Tanaka - NID
- Jill Watts - NID